Drug Trial Radar · NCT01065857
Safety and Efficacy Study of CitraFleet (Sodium Picosulphate) as an Evacuating Treatment Prior to Colonoscopy.
Last checked: Nov 19, 2026Latest source record: Apr 15, 2011 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
547
Planned (sponsor's estimate)
Start
Jan 2010
Primary completion
Jun 2010
Study completion Feb 2011
Sponsor
- Lead sponsor
- Laboratorios Casen-Fleet S.L.U.Industry
- Sponsor type
- Industry
- Collaborators
- Trial Form Support S.L.; Apices Soluciones S.L.
- First posted
- Feb 9, 2010
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Single (outcomes assessor)
- Who can join
- All sexes, from 18 years, up to 80 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to determine any significant differences in the efficacy and acceptability between CitraFleet and Klean Prep® (polyethylene glycol) for the preparation of gastrointestinal subjects undergoing a colon examination.
Conditions
- Subjects Undergoing a Complete Exploratory Diagnostic Colonoscopy for the First Time.
Interventions
Sodium picosulphate, light magnesium oxide and anhydride citric acid.Drug
2 Single-dose sachets containing sodium picosulphate (0.01g/sachet), light magnesium oxide (3.50g/sachet) and anhydrous citric acid (10.97g/sachet).
Polyethylene glycol, KCl, NaCl, sodium sulphate anhydrous and sodium bicarbonate.Drug
4 sachets containing Polyethylene glycol 3350 (59 gr), KCl (0.7425 gr), NaCl (1.465 gr), sodium sulphate anhydrous (5.685 gr), sodium bicarbonate (1.685 gr).
Primary outcomes
What the sponsor says the trial is designed to measure.
- Percentage of subjects that achieve 'excellent' or 'good' cleansing in the Fleet® Grading Scale for Bowel Cleansing.Time frame: 24 hours
- Percentage of subjects who find the agent easy to take or tolerable using a 5 point scale which assesses, the difficulty of taking the product, the degree of discomfort caused by it, and the taste of the drug, recorded in the subject questionnaireTime frame: 24 hours
Locations
15 sites in 1 country. Site status is shown where the registry gives one.
H. Universitari Vall´d Hebron
Barcelona, Barcelona, Spain
H. Clínic
Barcelona, Barcelona, Spain
H. General Universitario Reina Sofía
Córdoba, Córdoba, Spain
H. Universitario Virgen de las Nieves
Granada, Granada, Spain
H. General Universitario Gregorio Marañón
Madrid, Madrid, Spain
H. Universitario Puerta de Hierro
Madrid, Madrid, Spain
H. Infanta Elena
Valdemoro, Madrid, Spain
H. Regional Universitario Carlos Haya
Málaga, Málaga, Spain
H. Universitario Virgen de la Arrixaca
Murcia, Murcia, Spain
Clínica Universitaria de Navarra
Pamplona, Navarre, Spain
H. Universitario Central de Asturias
Oviedo, Oviedo, Spain
H. Virgen Macarena
Seville, Sevilla, Spain
H. Universitario de Canarias
San Cristóbal de La Laguna, Tenerife, Spain
H. Universitario La Fé
Valencia, Valencia, Spain
H. Basurto
Bilbao, Vizcaya, Spain
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.